API Suppliers
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
Other Certificates
0
Other Suppliers
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.fiercepharma.com/pharma/following-years-turmoil-and-resistance-allergan-preparing-to-split-analyst
https://endpts.com/allergan-chief-saunders-takes-a-painful-2-5b-hit-on-an-ugly-phiii-flop/
https://endpts.com/rat-study-suggests-allergans-failed-antidepressant-rapastinel-may-work-as-opioid-addiction-treatment/
https://www.prnewswire.com/news-releases/allergan-announces-phase-3-results-for-rapastinel-as-an-adjunctive-treatment-of-major-depressive-disorder-mdd-300808044.html